Skip to main content
. Author manuscript; available in PMC: 2022 Jul 12.
Published in final edited form as: J Gastrointest Surg. 2020 Jul 23;25(3):609–622. doi: 10.1007/s11605-020-04719-y

Table 3.

Bivariable and multivariable survival analysis for patients with pT4a and pT4 locally advanced gastric cancer who underwent margin-negative gastrectomy with multivisceral resection

Bivariable HR (95% CI)* Multivariable HR (95% CI)*
Age (years)
18–49 Reference Reference
50–64 0.98 (0.67–1.45) 0.93 (0.62–1.40)
65–74 0.78 (0.51–1.18) 0.84 (0.54–1.30)
≥ 75 1.54 (1.03–2.30) 1.36 (0.89–2.07)
Female sex 0.99 (0.62–1.59) 1.32 (1.02–1.71)
Race
White Reference
African-American 1.11 (0.82–1.50)
Asian-American 0.89 (0.55–1.42)
Hispanic ethnicity
Yes 1.07 (0.75–1.53)
Charlson-Deyo score
0 Reference Reference
1 1.57 (1.17–2.09) 1.41 (1.05–1.90)
≥ 2 1.13 (0.72–1.75) 1.29 (0.74–1.92)
Gastrectomy type
Subtotal Reference
Total 1.12 (0.86–1.45)
Gastrectomy unspecified 1.05 (0.72–1.55)
MVR
Yes 0.75 (0.47–1.20)
Primary tumor stage
T4b 1.17 (0.92–1.49)
Pathologic nodal stage
0 Reference Reference
1 1.36 (0.90–2.06) 1.61 (1.06–2.47)
2 1.18 (0.79–1.76) 1.45 (0.96–2.19)
3 2.35 (1.69–3.27) 2.69 (1.91–3.78)
Neoadjuvant chemotherapy
Yes 0.88 (0.66–1.16)
Neoadjuvant radiation
Yes 0.72 (0.27–1.94)
Adjuvant chemotherapy
Yes 0.59 (0.46–0.75) 0.75 (0.55–1.03)
Adjuvant radiation
Yes 0.64 (0.49–0.84) 0.77 (0.55–1.08)
*

Hazard ratios and 95% confidence intervals